$ABT News

Abbott Bypasses Appeals Process To Settle Ongoing Premature Infant Formula Litigation

SCHD: We Were Horribly Wrong

Abbott Bypasses Appeals Process To Settle Ongoing Premature Infant Formula Litigation

Can Abbott Laboratories (ABT)’s Instinct Sensor Give MiniMed Group (MMED) a Competitive Edge?

Abbott reaches agreements to resolve a portion of litigation involving its specialty formulas for preterm infants

Abbott Reaches ~$670M Settlement With Three Law Firms To Resolve Gill Case Involving ~2K Individuals Regarding Special Formulas For Pattern Infants

Abbott’s Point-Of-Care Testing Products To Be Distributed In The UK Through Avricore Health's Healthtab Platform

Abbott Laboratories: Diagnostics And Medical Devices Fuel Next Growth Phase (Downgrade)

Abbott Laboratories: Reasonably Valued After Surge, But Still An Attractive Buy Long-Term

Abbott (ABT) Stock Looks Reasonable On Earnings With Stronger Cash Flow

Recent Report Shows That Rep. Richard Dean Dr McCormick Sold Up to $375K Worth of Abbott Laboratories Stock

Wolfe Research Upgrades Abbott Laboratories (ABT)

Wolfe Research Upgrades Abbott Laboratories to Outperform, Announces $130 Price Target

What's Backing Abbott's Established Pharmaceuticals Division Growth

Wolfe Research downgrades Stryker, upgrades Abbott in med-tech shuffle

Abbott and Big Ten bring back 'We Give Blood' as U.S. faces blood supply crisis

Abbott and Google launch first-of-its-kind partnership to transform everyday health through glucose insights and AI

Abbott Partners With Google Health To Combine Glucose Insights From Abbott's Lingo Biowearable With Google's Expertise In AI To Make Personalized Metabolic Insights More Actionable

Abbott vs. Medtronic: Is Consistent Growth Better Than a Turnaround Story?

Should You Buy, Hold or Sell ABT Stock Amid Medical Devices Boom?